首页 > 最新文献

Turkish Journal of Pharmaceutical Sciences最新文献

英文 中文
In Vitro Anti-Aging Potential Evaluation of Maclura pomifera (Rafin.) Schneider 80% Methanol Extract with Quantitative HPTLC Analysis. 鱼尾草体外抗衰老潜力评价施耐德80%甲醇提取物的hplc定量分析。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.65087
Timur Hakan Barak, İnci Kurt Celep, Tuğba Buse Şentürk, Hilal Bardakcı, Engin Celep

Objectives: Maclura pomifera (Rafin.) Schneider is a widespread species all around the world, which is also frequently cultured for ornamental purposes. Previous studies revealed that M. pomifera fruits are rich in prenylated isoflavonoids, exhibit noteworthy biological activities, and have probable benefits, particularly, when applied topically. Considering that phenolic compounds are important sources in the development of anti-aging cosmetic products, this study investigated the anti-aging potential of M. pomifera 80% methanolic extract (MPM) by evaluating antioxidant and extracellular matrix degrading enzymes inhibiting activity.

Materials and methods: For this study, the inhibitory potential of 80% MPM against different enzymes associated with the aging process was evaluated. Given the unequivocal role of oxidative stress in aging, in vitro antioxidant tests were employed as well. Moreover, osajin was determined as the major bioactive isoflavonoid of the sample by high performance thin layer chromatography analysis.

Results: Results of the mechanistically different antioxidant assays exhibited notable antioxidant potential of the extract. Inhibition potential of MPM against hyaluronidase, collagenase, and elastase enzymes, which are directly linked to acceleration of the aging process, was investigated and results revealed that MPM inhibited the aforementioned enzymes explicitly. MPM had notable phenolic and flavonoid content; 113.92 ± 2.26 mg gallic acid equivalent/g and 66.41 ± 0.74 mg QE/g, respectively. When total antioxidant capacity assays were considered, it is possible to suggest that MPM is a promising anti-aging agent.

Conclusion: As a result, this study discloses that extracts of fruits of M. pomifera have significant anti-aging potential and may be used for this purpose.

目的:麦屈拉(Rafin.)施耐德是一个广泛分布在世界各地的物种,它也经常被培养为观赏目的。以往的研究表明,pomifera果实含有丰富的烯酰化异黄酮,具有显著的生物活性,特别是局部应用时可能具有一定的益处。考虑到酚类化合物是开发抗衰老化妆品的重要来源,本研究通过评价pomifera 80%甲醇提取物(MPM)的抗氧化活性和抑制细胞外基质降解酶的活性来研究其抗衰老潜力。材料和方法:在本研究中,80%的MPM对与衰老过程相关的不同酶的抑制潜力进行了评估。鉴于氧化应激在衰老中的明确作用,体外抗氧化试验也被采用。此外,通过高效薄层色谱分析,确定osajin是样品中主要的生物活性异黄酮。结果:不同机理的抗氧化实验均显示出明显的抗氧化潜力。研究了MPM对加速衰老过程直接相关的透明质酸酶、胶原酶和弹性酶的抑制潜力,结果表明MPM对上述酶有明显的抑制作用。其酚类和类黄酮含量显著;没食子酸当量分别为113.92±2.26 mg /g和66.41±0.74 mg QE/g。当考虑总抗氧化能力测定时,有可能表明MPM是一种有前途的抗衰老剂。结论:本研究揭示了pomifera果实提取物具有显著的抗衰老潜力,可用于抗衰老。
{"title":"<i>In Vitro</i> Anti-Aging Potential Evaluation of <i>Maclura pomifera</i> (Rafin.) Schneider 80% Methanol Extract with Quantitative HPTLC Analysis.","authors":"Timur Hakan Barak,&nbsp;İnci Kurt Celep,&nbsp;Tuğba Buse Şentürk,&nbsp;Hilal Bardakcı,&nbsp;Engin Celep","doi":"10.4274/tjps.galenos.2021.65087","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.65087","url":null,"abstract":"<p><strong>Objectives: </strong><i>Maclura pomifera</i> (Rafin.) Schneider is a widespread species all around the world, which is also frequently cultured for ornamental purposes. Previous studies revealed that <i>M. pomifera</i> fruits are rich in prenylated isoflavonoids, exhibit noteworthy biological activities, and have probable benefits, particularly, when applied topically. Considering that phenolic compounds are important sources in the development of anti-aging cosmetic products, this study investigated the anti-aging potential of <i>M. pomifera</i> 80% methanolic extract (MPM) by evaluating antioxidant and extracellular matrix degrading enzymes inhibiting activity.</p><p><strong>Materials and methods: </strong>For this study, the inhibitory potential of 80% MPM against different enzymes associated with the aging process was evaluated. Given the unequivocal role of oxidative stress in aging, <i>in vitro</i> antioxidant tests were employed as well. Moreover, osajin was determined as the major bioactive isoflavonoid of the sample by high performance thin layer chromatography analysis.</p><p><strong>Results: </strong>Results of the mechanistically different antioxidant assays exhibited notable antioxidant potential of the extract. Inhibition potential of MPM against hyaluronidase, collagenase, and elastase enzymes, which are directly linked to acceleration of the aging process, was investigated and results revealed that MPM inhibited the aforementioned enzymes explicitly. MPM had notable phenolic and flavonoid content; 113.92 ± 2.26 mg gallic acid equivalent/g and 66.41 ± 0.74 mg QE/g, respectively. When total antioxidant capacity assays were considered, it is possible to suggest that MPM is a promising anti-aging agent.</p><p><strong>Conclusion: </strong>As a result, this study discloses that extracts of fruits of <i>M. pomifera</i> have significant anti-aging potential and may be used for this purpose.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"400-407"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438754/pdf/TJPS-19-400.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40336030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
In Vitro Antioxidant and Enzyme Inhibition Activity of Tanacetum argyrophyllum (K. Koch) Tzvelev var. argyrophyllum Extract. 叶香Tanacetum argyrophylum (K. Koch) Tzvelev var. argyrophylum提取物体外抗氧化及酶抑制活性研究。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.96493
Nuraniye Eruygur, Kevser Taban Akça, Osman Üstün, Mehmet Tekin

Objectives: Tanacetum L. belongs to Asteraceae family and is represented by 46 species in Türkiye. Tanacetum genus is known for its insecticide and insect repellent effect. T. argyrophyllum contains sesquiterpene lactone derivatives. These compounds are responsible for its various activities, especially cytotoxic, antitumor, phytotoxic, antimicrobial, antiviral, and antifungal activity. There are not enough biological activity studies on the plant that are likely to have a wide variety of activities in terms of the compounds it contains. The aim of the present study is to evaluate various biological activities of 80% aqueous methanol extract prepared from aerial parts of T. argyrophyllum (K. Koch) Tzvelev var. argyrophyllum collected from Sivas province of Turkey.

Materials and methods: Antioxidant activity of the methanol extract was determined by 2,2'-diphenyl-1-picryl-hydrazyl and 2,2-azinobis (3-ethyl benzothiazoline-6-sulfonic acid) radical scavenging activity, total phenolic, and total flavonoid content tests. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities were investigated via Ellman's spectrometric method.

Results: Total phenolic content was found as 71.67 mg/gallic acid equivalent g and total flavonoid content was 25.225 mg/quercetin equivalent g on a dry extract weight basis. In this work, AChE, BChE, and α-glycosidase enzymes were inhibited by the extract of T. argyrophyllum var. argyrophyllum. IC50 values for these enzymes were found as 266.79 µg/mL for AChE and 176.91 µg/mL for BChE. Also, the α-glycosidase activity exhibited a dose-dependent manner with increasing concentration.

Conclusion: According to the results, T. argyrophyllum var. argyrophyllum can be used as an ingredient of functional foods as well as herbal products for diabetic and Alzheimer's disease patients.

目的:唐菖蒲属菊科植物,在我国有46种。Tanacetum属以其杀虫剂和驱虫作用而闻名。松香含有倍半萜内酯衍生物。这些化合物负责其各种活性,特别是细胞毒性,抗肿瘤,植物毒性,抗菌,抗病毒和抗真菌活性。目前对这种植物的生物活性研究还不够,就其所含化合物而言,这种植物可能具有多种活性。本研究的目的是评价从土耳其西瓦斯省(Sivas province)采来的argyrophyllum (K. Koch) Tzvelev var. argyrophyllum的地上部分制备的80%甲醇水溶液提取物的各种生物活性。材料与方法:采用2,2′-二苯基-1-吡啶-肼和2,2-氮唑(3-乙基苯并噻唑-6-磺酸)自由基清除活性、总酚和总黄酮含量测定甲醇提取物的抗氧化活性。采用埃尔曼光谱法测定其对乙酰胆碱酯酶(AChE)和丁基胆碱酯酶(BChE)的抑制活性。结果:以干提取物重量计,总酚含量为71.67 mg/没食子酸当量g,总黄酮含量为25.225 mg/槲皮素当量g。在本实验中,香椿提取物对乙酰胆碱酯酶(AChE)、乙酰胆碱酯酶(BChE)和α-糖苷酶(α-糖苷酶)有抑制作用。AChE和BChE的IC50值分别为266.79µg/mL和176.91µg/mL。α-糖苷酶活性随浓度的增加呈剂量依赖性。结论:根据本研究结果,银叶芝可作为糖尿病和阿尔茨海默病患者功能性食品的成分,也可作为中草药产品的成分。
{"title":"<i>In Vitro</i> Antioxidant and Enzyme Inhibition Activity of <i>Tanacetum argyrophyllum</i> (K. Koch) Tzvelev var. <i>argyrophyllum</i> Extract.","authors":"Nuraniye Eruygur,&nbsp;Kevser Taban Akça,&nbsp;Osman Üstün,&nbsp;Mehmet Tekin","doi":"10.4274/tjps.galenos.2021.96493","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.96493","url":null,"abstract":"<p><strong>Objectives: </strong><i>Tanacetum</i> L. belongs to Asteraceae family and is represented by 46 species in Türkiye. <i>Tanacetum</i> genus is known for its insecticide and insect repellent effect. <i>T. argyrophyllum</i> contains sesquiterpene lactone derivatives. These compounds are responsible for its various activities, especially cytotoxic, antitumor, phytotoxic, antimicrobial, antiviral, and antifungal activity. There are not enough biological activity studies on the plant that are likely to have a wide variety of activities in terms of the compounds it contains. The aim of the present study is to evaluate various biological activities of 80% aqueous methanol extract prepared from aerial parts of <i>T. argyrophyllum</i> (K. Koch) Tzvelev var. <i>argyrophyllum</i> collected from Sivas province of Turkey.</p><p><strong>Materials and methods: </strong>Antioxidant activity of the methanol extract was determined by 2,2'-diphenyl-1-picryl-hydrazyl and 2,2-azinobis (3-ethyl benzothiazoline-6-sulfonic acid) radical scavenging activity, total phenolic, and total flavonoid content tests. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities were investigated <i>via</i> Ellman's spectrometric method.</p><p><strong>Results: </strong>Total phenolic content was found as 71.67 mg/gallic acid equivalent g and total flavonoid content was 25.225 mg/quercetin equivalent g on a dry extract weight basis. In this work, AChE, BChE, and α-glycosidase enzymes were inhibited by the extract of <i>T. argyrophyllum</i> var. <i>argyrophyllum</i>. IC<sub>50</sub> values for these enzymes were found as 266.79 µg/mL for AChE and 176.91 µg/mL for BChE. Also, the α-glycosidase activity exhibited a dose-dependent manner with increasing concentration.</p><p><strong>Conclusion: </strong>According to the results, <i>T. argyrophyllum</i> var. <i>argyrophyllum</i> can be used as an ingredient of functional foods as well as herbal products for diabetic and Alzheimer's disease patients.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"377-382"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438756/pdf/TJPS-19-377.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40335675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line. 硼砂(四硼酸钠)和5-氟尿嘧啶联合应用对DLD-1人结直肠癌细胞株的细胞毒性和凋亡作用
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.29726
Ömer Faruk Kırlangıç, Ecem Kaya-Sezginer, Sema Ören, Serap Gür, Özlem Yavuz, Taner Özgürtaş

Objectives: Colorectal cancer (CRC) remains a crucial health problem due to the toxicity of 5-Fluorouracil (5-FU) as first-line chemotherapy agent for treating CRC. The anticancer effects of boron and its compounds have been shown in various cell lines. This study aimed to examine the cytotoxic and apoptotic effects of borax (sodium tetraborate) alone or along with 5-FU on human CRC cells, DLD-1.

Materials and methods: Cytotoxicity and apoptosis were determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, 4',6-diamidino-2-phenylindole and annexin V/propidium iodide staining.

Results: The results showed that combined treatment revealed a significant time- and concentration-dependent cytotoxic effect on DLD-1 cells compared with borax or 5-FU treatment alone. The combination of borax and 5-FU induced a clear increase in the early apoptotic cell percentage, compared to the cells treated with monotherapies. Additionally, a significant increase in condensed and fragmented nuclei was detected in DLD-1 cells treated with the combination treatment compared with borax or 5-FU alone.

Conclusion: Our current findings suggest that the combination of borax with 5-FU has a strong cytotoxic and apoptotic effect on the human CRC DLD-1 cells.

目的:由于5-氟尿嘧啶(5-FU)作为治疗结直肠癌的一线化疗药物的毒性,结直肠癌(CRC)仍然是一个重要的健康问题。硼及其化合物的抗癌作用已在多种细胞系中得到证实。本研究旨在探讨硼砂(四硼酸钠)单独或联合5-FU对人结直肠癌细胞DLD-1的细胞毒性和凋亡作用。材料和方法:采用3-(4,5-二甲基噻唑-2)-2,5-二苯基溴化四唑(MTT)法、4′,6-二氨基-2-苯基吲哚和膜联蛋白V/碘化丙啶染色法测定细胞毒性和细胞凋亡。结果:与单独硼砂或5-FU治疗相比,联合治疗对DLD-1细胞的细胞毒作用表现出明显的时间和浓度依赖性。与单药治疗相比,硼砂和5-FU联合用药可明显增加早期凋亡细胞的百分比。此外,与单独使用硼砂或5-FU相比,在联合处理的DLD-1细胞中检测到浓缩和碎片化细胞核的显著增加。结论:硼砂联合5-FU对人结直肠癌DLD-1细胞具有较强的细胞毒性和凋亡作用。
{"title":"Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line.","authors":"Ömer Faruk Kırlangıç,&nbsp;Ecem Kaya-Sezginer,&nbsp;Sema Ören,&nbsp;Serap Gür,&nbsp;Özlem Yavuz,&nbsp;Taner Özgürtaş","doi":"10.4274/tjps.galenos.2021.29726","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.29726","url":null,"abstract":"<p><strong>Objectives: </strong>Colorectal cancer (CRC) remains a crucial health problem due to the toxicity of 5-Fluorouracil (5-FU) as first-line chemotherapy agent for treating CRC. The anticancer effects of boron and its compounds have been shown in various cell lines. This study aimed to examine the cytotoxic and apoptotic effects of borax (sodium tetraborate) alone or along with 5-FU on human CRC cells, DLD-1.</p><p><strong>Materials and methods: </strong>Cytotoxicity and apoptosis were determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, 4',6-diamidino-2-phenylindole and annexin V/propidium iodide staining.</p><p><strong>Results: </strong>The results showed that combined treatment revealed a significant time- and concentration-dependent cytotoxic effect on DLD-1 cells compared with borax or 5-FU treatment alone. The combination of borax and 5-FU induced a clear increase in the early apoptotic cell percentage, compared to the cells treated with monotherapies. Additionally, a significant increase in condensed and fragmented nuclei was detected in DLD-1 cells treated with the combination treatment compared with borax or 5-FU alone.</p><p><strong>Conclusion: </strong>Our current findings suggest that the combination of borax with 5-FU has a strong cytotoxic and apoptotic effect on the human CRC DLD-1 cells.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"371-376"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438760/pdf/TJPS-19-371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40336867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development of GC-MS/MS Method for Simultaneous Estimation of Four Nitrosoamine Genotoxic Impurities in Valsartan. 同时测定缬沙坦中4种亚硝基胺遗传毒性杂质的GC-MS/MS方法的建立。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.17702
Sambasiva Rao Tummala, Krishnamanjari Pawar Amgoth

Objectives: Recently, N-nitrosamines were unexpectedly detected in valsartan and other generic sartan products. Taking into this account, we developed a sensitive and stable multiple reaction monitoring mode-based "gas chromatography-tandem mass spectrometry (GC-MS/MS)" approach for the quantification of "four N-nitrosamines" in valsartan, especially, N-nitrosodiisopropylamine, N-nitroso ethyl isopropylamine, N-nitrosodiethylamine, and N-nitrosodimethylamine.

Materials and methods: GC and MS conditions were optimized with specificity, sensitivity, linearity, precision, and accuracy of the parameters. The approach was validated as per the "International Council for Harmonization" recommendations.

Results: The identification limits and limits of quantification of N-nitrosamines in valsartan varied between 0.02 and 0.03 ppm, and 0.06-0.09 ppm, respectively. The obtained values were satisfactory with limits established by the United States Food and Drug Administration for sensitivity requirements. The regression coefficients greater than 0.999 for four N-nitrosamines in the calibration curve demonstrated the strong linearity of the process. The retrievals of "N-nitrosamines" in valsartan between 91.9-122.7%. For the intra-day and inter-day accuracy studies, the (relative standard deviation) was less than 9.15%.

Conclusion: The proposed approach has rapid analysis capability, high precision, accuracy, and good sensitivity, which give a reliable approach for N-nitrosamines quality control in valsartan.

目的:最近,在缬沙坦和其他仿制沙坦产品中意外检测到n -亚硝胺。考虑到这一点,我们建立了一种灵敏稳定的基于多反应监测模式的“气相色谱-串联质谱(GC-MS/MS)”方法来定量缬沙坦中的“四种n -亚硝胺”,特别是n -亚硝基二异丙胺、n -亚硝基乙基异丙胺、n -亚硝基二乙胺和n -亚硝基二甲胺。材料和方法:对色谱和质谱条件进行了特异性、灵敏度、线性度、精密度和准确度的优化。根据“国际协调理事会”的建议,该方法得到了验证。结果:缬沙坦中n -亚硝胺的检出限和定量限分别为0.02 ~ 0.03 ppm和0.06 ~ 0.09 ppm。所得值符合美国食品和药物管理局制定的敏感性要求限值。4种n -亚硝胺在标定曲线上的回归系数均大于0.999,表明该方法具有较强的线性关系。缬沙坦中n -亚硝胺的检出率在91.9 ~ 122.7%之间。日内和日间准确度研究(相对标准偏差)均小于9.15%。结论:该方法分析速度快,精密度、准确度高,灵敏度好,可作为缬沙坦中n -亚硝胺类药物质量控制的可靠方法。
{"title":"Development of GC-MS/MS Method for Simultaneous Estimation of Four Nitrosoamine Genotoxic Impurities in Valsartan.","authors":"Sambasiva Rao Tummala,&nbsp;Krishnamanjari Pawar Amgoth","doi":"10.4274/tjps.galenos.2021.17702","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.17702","url":null,"abstract":"<p><strong>Objectives: </strong>Recently, <i>N</i>-nitrosamines were unexpectedly detected in valsartan and other generic sartan products. Taking into this account, we developed a sensitive and stable multiple reaction monitoring mode-based \"gas chromatography-tandem mass spectrometry (GC-MS/MS)\" approach for the quantification of \"four <i>N</i>-nitrosamines\" in valsartan, especially, <i>N</i>-nitrosodiisopropylamine, <i>N</i>-nitroso ethyl isopropylamine, <i>N</i>-nitrosodiethylamine, and <i>N</i>-nitrosodimethylamine.</p><p><strong>Materials and methods: </strong>GC and MS conditions were optimized with specificity, sensitivity, linearity, precision, and accuracy of the parameters. The approach was validated as <i>per</i> the \"International Council for Harmonization\" recommendations.</p><p><strong>Results: </strong>The identification limits and limits of quantification of <i>N</i>-nitrosamines in valsartan varied between 0.02 and 0.03 ppm, and 0.06-0.09 ppm, respectively. The obtained values were satisfactory with limits established by the United States Food and Drug Administration for sensitivity requirements. The regression coefficients greater than 0.999 for four <i>N</i>-nitrosamines in the calibration curve demonstrated the strong linearity of the process. The retrievals of \"<i>N</i>-nitrosamines\" in valsartan between 91.9-122.7%. For the intra-day and inter-day accuracy studies, the (relative standard deviation) was less than 9.15%.</p><p><strong>Conclusion: </strong>The proposed approach has rapid analysis capability, high precision, accuracy, and good sensitivity, which give a reliable approach for <i>N</i>-nitrosamines quality control in valsartan.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"455-461"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438752/pdf/TJPS-19-455.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40336942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Development and Characterization of Hygroscopicity-Controlled Sustain Release Formulation of Divalproex Sodium. 双丙戊酸钠吸湿控释制剂的研制与表征。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.57615
Saurav Adhikari, Uttam Budhathoki, Panna Thapa

Objectives: Divalproex sodium (DS), being a hygroscopic drug, requires low humidity during product manufacturing. This study aims to develop a hygroscopicity controlled sustained release formulation of DS that can be manufactured in relatively high humid conditions in facilities lacking dehumidifiers.

Materials and methods: This study focuses on the role of polyethylene glycol (PEG-8000) and hydroxypropyl methylcellulose (HPMC K100M) as polymers of choice to control hygroscopicity and retard release of DS using solid dispersion technique. In this study, homogeneous solid dispersions containing various ratios of PEG-8000, HPMC K100M, and DS were obtained via melt granulation technique. Fifteen different solid dispersions were prepared based on Box-Behnken experimental design created in MiniTab software. The obtained solid dispersions were separately broken down into granules and their hygroscopic properties were determined via moisture uptake studies. Granular solid dispersions were then compressed into tablets and their sustained release dissolution profiles were studied as per the United States Pharmacopoeia (USP) monograph of DS extended-release tablets. Dissolution profiles of all fifteen formulations were then analyzed in Box-Behnken experimental design under MiniTab software to determine an optimized formulation having low hygroscopic properties as well as required multipoint drug release as per USP monograph. The final optimized formulation was prepared and subjected to moisture uptake study to determine its hygroscopicity, dissolution study to determine drug release kinetics and fourier transform infrared (FTIR) and differential scanning calorimetry (DSC) analysis to determine molecular interactions between drug and polymers.

Result: Optimized final formulation yielded granular solid dispersion with 28% less hygroscopicity compared to DS and tablets with an excellent release profile in accordance with USP monograph. FTIR and DSC analysis did not show any significant interaction between DS and components of the solid dispersion.

Conclusion: Optimized formulation from this study can be used to manufacture divalproex extended-release tablets inside facilities lacking dehumidifiers.

目的:双丙戊酸钠(DS)是一种吸湿性药物,在生产过程中需要较低的湿度。本研究旨在开发一种吸湿性控制的DS缓释制剂,该制剂可以在缺乏除湿机的相对高湿度条件下生产。材料和方法:本研究主要研究了聚乙二醇(PEG-8000)和羟丙基甲基纤维素(HPMC K100M)作为首选聚合物,利用固体分散技术控制DS的吸湿性和延缓DS的释放。在本研究中,通过熔融造粒技术获得了含有不同比例PEG-8000、HPMC K100M和DS的均匀固体分散体。基于MiniTab软件创建的Box-Behnken实验设计,制备了15种不同的固体分散体。将得到的固体分散体分别分解成颗粒,并通过吸湿研究确定其吸湿性能。将颗粒状固体分散体压缩成片剂,并根据美国药典DS缓释片各论研究其缓释溶出度。然后在MiniTab软件下使用Box-Behnken实验设计分析所有15种配方的溶出曲线,以确定具有低吸湿性和根据USP各论要求的多点药物释放的优化配方。制备最终优化制剂,并对其吸湿性进行吸湿性研究,溶出性进行药物释放动力学研究,傅里叶变换红外(FTIR)和差示扫描量热(DSC)分析,确定药物与聚合物之间的分子相互作用。结果:优化后的最终配方比DS和片剂的吸湿性降低28%,具有良好的释放特性,符合USP各论。FTIR和DSC分析没有显示DS和固体分散组分之间有显著的相互作用。结论:该优化处方可用于在无除湿设备内生产双丙戊酸缓释片。
{"title":"Development and Characterization of Hygroscopicity-Controlled Sustain Release Formulation of Divalproex Sodium.","authors":"Saurav Adhikari,&nbsp;Uttam Budhathoki,&nbsp;Panna Thapa","doi":"10.4274/tjps.galenos.2021.57615","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.57615","url":null,"abstract":"<p><strong>Objectives: </strong>Divalproex sodium (DS), being a hygroscopic drug, requires low humidity during product manufacturing. This study aims to develop a hygroscopicity controlled sustained release formulation of DS that can be manufactured in relatively high humid conditions in facilities lacking dehumidifiers.</p><p><strong>Materials and methods: </strong>This study focuses on the role of polyethylene glycol (PEG-8000) and hydroxypropyl methylcellulose (HPMC K100M) as polymers of choice to control hygroscopicity and retard release of DS using solid dispersion technique. In this study, homogeneous solid dispersions containing various ratios of PEG-8000, HPMC K100M, and DS were obtained <i>via</i> melt granulation technique. Fifteen different solid dispersions were prepared based on Box-Behnken experimental design created in MiniTab software. The obtained solid dispersions were separately broken down into granules and their hygroscopic properties were determined <i>via</i> moisture uptake studies. Granular solid dispersions were then compressed into tablets and their sustained release dissolution profiles were studied as <i>per</i> the United States Pharmacopoeia (USP) monograph of DS extended-release tablets. Dissolution profiles of all fifteen formulations were then analyzed in Box-Behnken experimental design under MiniTab software to determine an optimized formulation having low hygroscopic properties as well as required multipoint drug release as <i>per</i> USP monograph. The final optimized formulation was prepared and subjected to moisture uptake study to determine its hygroscopicity, dissolution study to determine drug release kinetics and fourier transform infrared (FTIR) and differential scanning calorimetry (DSC) analysis to determine molecular interactions between drug and polymers.</p><p><strong>Result: </strong>Optimized final formulation yielded granular solid dispersion with 28% less hygroscopicity compared to DS and tablets with an excellent release profile in accordance with USP monograph. FTIR and DSC analysis did not show any significant interaction between DS and components of the solid dispersion.</p><p><strong>Conclusion: </strong>Optimized formulation from this study can be used to manufacture divalproex extended-release tablets inside facilities lacking dehumidifiers.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"422-430"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438761/pdf/TJPS-19-422.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40337044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease. 几种药用植物次级代谢物作为新型冠状病毒主要蛋白酶潜在抑制剂的分子对接研究
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-31 DOI: 10.4274/tjps.galenos.2021.83548
Sinan Bilginer, Sefa Gözcü, Zuhal Güvenalp
ObjectivesCoronaviruses (CoVs) cause infections that affect the respiratory tract, liver, central nervous, and the digestive systems in humans and animals. This study focused on the main protease (Mpro) in CoVs (PDB ID: 6LU7) that is used as a potential drug target to combat 2019-CoV. In this study, a total of 35 secondary metabolites from medical plants was selected and docked into the active site of 6LU7 by molecular docking studies to find a potential inhibitory compound that may be used to inhibit Coronavirus Disease-2019 (COVID-19) infection pathway.Materials and MethodsThe chemical structures of the ligands were obtained from the Drug Bank (https://www.drugbank.ca/). AutoDockTools (ADT ver. 1.5.6) was used for molecular docking studies. The docking results were evaluated using BIOVIA Discovery Studio Visualizer and PyMOL (ver. 2.3.3, Schrodinger, LLC).ResultsPycnamine, tetrahydrocannabinol, oleuropein, quercetin, primulic acid, kaempferol, dicannabidiol, lobelin, colchicine, piperidine, medicagenic acid, and narcotine is found to be potential inhibitors of the COVID-19 Mpro. Among these compounds, pycnamine, which was evaluated against COVID-19 for the first time, showed a high affinity to the COVID-19 Mpro compared with other seconder metabolites and reference drugs.ConclusionOur results obtained from docking studies suggest that pycnamine should be examined in vitro to combat 2019-CoV. Moreover, pycnamine might be a promising lead compound for anti-CoV drugs.
目的:冠状病毒(cov)引起感染,影响人类和动物的呼吸道、肝脏、中枢神经和消化系统。这项研究的重点是冠状病毒的主要蛋白酶(Mpro) (PDB ID: 6LU7),它被用作对抗2019-CoV的潜在药物靶点。本研究从药用植物中选取35种次生代谢物,通过分子对接研究,将其对接到6LU7的活性位点,寻找可能用于抑制冠状病毒病-2019 (COVID-19)感染途径的潜在抑制化合物。材料和方法:配体的化学结构来源于药物库(https://www.drugbank.ca/)。AutoDockTools (ADT版本)1.5.6)进行分子对接研究。对接结果使用BIOVIA Discovery Studio Visualizer和PyMOL (ver. net .)进行评估。2.3.3, Schrodinger, LLC)。结果:发现pypyamine、tetrahydrocannabinol、橄榄苦苷、槲皮素、primulic acid、山奈酚、大麻二醇、血红蛋白、秋水仙碱、胡椒碱、药原酸、那曲汀是潜在的COVID-19 Mpro抑制剂。其中,与其他次级代谢物和参比药物相比,首次对新冠病毒进行抗病毒评价的pycnamine对新冠病毒Mpro具有较高的亲和力。结论:对接研究结果表明,应在体外检测吡喹那明对抗2019-CoV的能力。此外,苯胺可能是抗冠状病毒药物的一种有前途的先导化合物。
{"title":"Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease.","authors":"Sinan Bilginer,&nbsp;Sefa Gözcü,&nbsp;Zuhal Güvenalp","doi":"10.4274/tjps.galenos.2021.83548","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.83548","url":null,"abstract":"Objectives\u0000Coronaviruses (CoVs) cause infections that affect the respiratory tract, liver, central nervous, and the digestive systems in humans and animals. This study focused on the main protease (Mpro) in CoVs (PDB ID: 6LU7) that is used as a potential drug target to combat 2019-CoV. In this study, a total of 35 secondary metabolites from medical plants was selected and docked into the active site of 6LU7 by molecular docking studies to find a potential inhibitory compound that may be used to inhibit Coronavirus Disease-2019 (COVID-19) infection pathway.\u0000\u0000\u0000Materials and Methods\u0000The chemical structures of the ligands were obtained from the Drug Bank (https://www.drugbank.ca/). AutoDockTools (ADT ver. 1.5.6) was used for molecular docking studies. The docking results were evaluated using BIOVIA Discovery Studio Visualizer and PyMOL (ver. 2.3.3, Schrodinger, LLC).\u0000\u0000\u0000Results\u0000Pycnamine, tetrahydrocannabinol, oleuropein, quercetin, primulic acid, kaempferol, dicannabidiol, lobelin, colchicine, piperidine, medicagenic acid, and narcotine is found to be potential inhibitors of the COVID-19 Mpro. Among these compounds, pycnamine, which was evaluated against COVID-19 for the first time, showed a high affinity to the COVID-19 Mpro compared with other seconder metabolites and reference drugs.\u0000\u0000\u0000Conclusion\u0000Our results obtained from docking studies suggest that pycnamine should be examined in vitro to combat 2019-CoV. Moreover, pycnamine might be a promising lead compound for anti-CoV drugs.","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":"431-441"},"PeriodicalIF":1.7,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438759/pdf/TJPS-19-431.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40337046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article. 过氧化物酶体增殖物激活受体作为治疗糖尿病的优越靶点,设计策略-综述文章。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-06-27 DOI: 10.4274/tjps.galenos.2021.70105
Mohammed T Qaoud, Ihab Almasri, Tijen Önkol
Thiazolidinedione (TZD), a class of drugs that are mainly used to control type 2 diabetes mellitus (T2DM), acts fundamentally as a ligand of peroxisome proliferator-activated receptors (PPARs). Besides activating pathways responsible for glycemic control by enhancing insulin sensitivity and lipid homeostasis, activating PPARs leads to exciting other pathways related to bone formation, inflammation, and cell proliferation. Unfortunately, this diverse effect of activating several pathways may show in some studies adverse health outcomes as osteological, hepatic, cardiovascular, and carcinogenic effects. Thus, a silver demand is present to find and develop new active and potent antiglycemic drugs for treating T2DM. To achieve this goal, the structure of TZD for research is considered a leading structure domain. This review will guide future research in the design of novel TZD derivatives by highlighting the general modifications conducted on the structure component of TZD scaffold affecting their potency, binding efficacy, and selectivity for the control of T2DM.
噻唑烷二酮(TZD)是一类主要用于控制2型糖尿病(T2DM)的药物,其主要作用是过氧化物酶体增殖物激活受体(ppar)的配体。除了通过增强胰岛素敏感性和脂质稳态来激活负责控制血糖的途径外,激活ppar还会激活与骨形成、炎症和细胞增殖相关的其他途径。不幸的是,在一些研究中,激活几种途径的不同效果可能显示出对骨骼、肝脏、心血管和致癌等健康不利的影响。因此,目前对银的需求是发现和开发新的有效的治疗2型糖尿病的降糖药物。为了实现这一目标,研究的TZD结构被认为是一个领先的结构领域。这篇综述将通过强调对TZD支架结构成分进行的一般修饰来影响其效力、结合功效和控制T2DM的选择性,从而指导未来新型TZD衍生物的设计研究。
{"title":"Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article.","authors":"Mohammed T Qaoud,&nbsp;Ihab Almasri,&nbsp;Tijen Önkol","doi":"10.4274/tjps.galenos.2021.70105","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.70105","url":null,"abstract":"Thiazolidinedione (TZD), a class of drugs that are mainly used to control type 2 diabetes mellitus (T2DM), acts fundamentally as a ligand of peroxisome proliferator-activated receptors (PPARs). Besides activating pathways responsible for glycemic control by enhancing insulin sensitivity and lipid homeostasis, activating PPARs leads to exciting other pathways related to bone formation, inflammation, and cell proliferation. Unfortunately, this diverse effect of activating several pathways may show in some studies adverse health outcomes as osteological, hepatic, cardiovascular, and carcinogenic effects. Thus, a silver demand is present to find and develop new active and potent antiglycemic drugs for treating T2DM. To achieve this goal, the structure of TZD for research is considered a leading structure domain. This review will guide future research in the design of novel TZD derivatives by highlighting the general modifications conducted on the structure component of TZD scaffold affecting their potency, binding efficacy, and selectivity for the control of T2DM.","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 3","pages":"353-370"},"PeriodicalIF":1.7,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254082/pdf/TJPS-19-353.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40462261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Safety of Herbal Medicines (Phytovigilance) from Community Pharmacists' Perspective: A Cross-Sectional Study. 社区药师视角下的草药安全性(植物警戒):一项横断面研究。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-06-27 DOI: 10.4274/tjps.galenos.2021.77178
Merve Memişoğlu, Gizem Otlatıcı

Objectives: The "safe if natural" perception of herbal products may have several undesirable side effects. It is important to raise awareness in public order to change this perception and ensure safer use of herbal products. The role of pharmacists is to supply herbal medicines safely and to provide accurate information to the patients about herbal products. The aim of this study was to analyze the perspective, knowledge, attitude, and behavior of community pharmacists about phytovigilance.

Materials and methods: A cross-sectional analysis was performed using community pharmacists (n= 879) using face-to-face surveys between April-June 2019 in Istanbul. For statistical analysis, student's t-test and one-way ANOVA were used to compare the mean values of the groups.

Results: It was determined that 58.1% of the pharmacists heard phytovigilance for the first time and 93.5% of them had not reported any safety-related herbal medicine reported so far. Among the reasons for not reporting, well-known adverse reactions were found to be 24.2% and the difficulty of reporting was found to be 21.8%. 84.6% of pharmacists have never received training related to phytovigilance. It was found that pharmacists with a working experience of more than 20 years primarily selected herbal products provided in their pharmacy based on the manufacturing company primarily, whereas others selected based on the efficacy of the products.

Conclusion: The results of this study have revealed the necessity to increase training on the safety of herbal medicines to cover all stakeholders and to give due importance to phytovigilance. The phytovigilance systems established in some countries for public health should be expanded to other countries. There is a need for a more user-friendly reporting system to increase adverse reaction reporting by pharmacists and other healthcare professionals. In the future, plan to perform studies to raise awareness in the public and promote reporting with digital technologies.

目的:“天然安全”的草药产品可能有一些不良的副作用。重要的是要提高公众的认识,以改变这种看法,并确保更安全地使用草药产品。药剂师的作用是安全提供草药,并向患者提供有关草药产品的准确信息。本研究的目的是分析社区药师对植物警戒的看法、知识、态度和行为。材料和方法:2019年4月至6月在伊斯坦布尔通过面对面调查使用社区药剂师(n= 879)进行横断面分析。统计分析采用学生t检验和单因素方差分析比较各组的平均值。结果:58.1%的药师第一次听说过植物警戒,93.5%的药师至今未报告过安全相关中药。未报告的原因中,已知不良反应占24.2%,报告困难占21.8%。84.6%的药师从未接受过植物警戒相关培训。研究发现,具有20年以上工作经验的药剂师主要根据生产公司选择其药房提供的草药产品,而其他药剂师主要根据产品的功效选择草药产品。结论:本研究结果揭示了加强草药安全培训的必要性,以覆盖所有利益相关者,并给予植物警戒应有的重视。一些国家为公共卫生建立的植物警戒系统应扩大到其他国家。需要一个更加用户友好的报告系统,以增加药剂师和其他医疗保健专业人员的不良反应报告。未来,计划开展研究,提高公众的意识,并推广使用数字技术进行报道。
{"title":"The Safety of Herbal Medicines (Phytovigilance) from Community Pharmacists' Perspective: A Cross-Sectional Study.","authors":"Merve Memişoğlu,&nbsp;Gizem Otlatıcı","doi":"10.4274/tjps.galenos.2021.77178","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.77178","url":null,"abstract":"<p><strong>Objectives: </strong>The \"safe if natural\" perception of herbal products may have several undesirable side effects. It is important to raise awareness in public order to change this perception and ensure safer use of herbal products. The role of pharmacists is to supply herbal medicines safely and to provide accurate information to the patients about herbal products. The aim of this study was to analyze the perspective, knowledge, attitude, and behavior of community pharmacists about phytovigilance.</p><p><strong>Materials and methods: </strong>A cross-sectional analysis was performed using community pharmacists (n= 879) using face-to-face surveys between April-June 2019 in Istanbul. For statistical analysis, student's t-test and one-way ANOVA were used to compare the mean values of the groups.</p><p><strong>Results: </strong>It was determined that 58.1% of the pharmacists heard phytovigilance for the first time and 93.5% of them had not reported any safety-related herbal medicine reported so far. Among the reasons for not reporting, well-known adverse reactions were found to be 24.2% and the difficulty of reporting was found to be 21.8%. 84.6% of pharmacists have never received training related to phytovigilance. It was found that pharmacists with a working experience of more than 20 years primarily selected herbal products provided in their pharmacy based on the manufacturing company primarily, whereas others selected based on the efficacy of the products.</p><p><strong>Conclusion: </strong>The results of this study have revealed the necessity to increase training on the safety of herbal medicines to cover all stakeholders and to give due importance to phytovigilance. The phytovigilance systems established in some countries for public health should be expanded to other countries. There is a need for a more user-friendly reporting system to increase adverse reaction reporting by pharmacists and other healthcare professionals. In the future, plan to perform studies to raise awareness in the public and promote reporting with digital technologies.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 3","pages":"280-286"},"PeriodicalIF":1.7,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254090/pdf/TJPS-19-280.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40574608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Non-Oral Drug Delivery in Parkinson's Disease: Current Applications and Future. 帕金森病的非口服给药:目前的应用和未来。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-06-27 DOI: 10.4274/tjps.galenos.2021.95226
Meliha Güneş, Sinem Yaprak Karavana

Parkinson's disease (PD) is a type of movement disorder that affects the ability to perform daily activities. It is considered that 1 million people in the U.S. and more than 10 million people worldwide live with PD. It is a chronic and progressive disease, so symptoms worsen over the time. Patients experience motor symptoms such as tremors, stiffness and slow motion, and non-motor symptoms such as sleep problems, constipation, anxiety, depression and fatigue. Dopaminergic drugs are critical for treating motor symptoms in PD. Levodopa (L-DOPA) is the "gold standard" medication for the control of motor symptoms. Because of the progression of the disease, the effectiveness of oral L-DOPA decreases over time and motor fluctuations such as "delayed ON", "no ON" and unpredictable "ON-OFF" periods appear. These motor fluctuations affect the quality of life of the patient at a high rate and the patient has problems in fulfilling his daily morning routines. Gastrointestinal (GI) problems, as the common non-motor symptom, are the most important cause of motor fluctuations that occur because of inadequate oral treatment with the progression of PD. When oral treatments are not sufficient, non-oral treatments that are not affected by GI problems are required. In this review, the treatment strategies, developed and approved non-oral drug delivery systems in the early and advanced stages of PD are emphasized.

帕金森病(PD)是一种影响日常活动能力的运动障碍。据估计,美国有100万人患有PD,全世界有1000多万人患有PD。这是一种慢性进行性疾病,因此症状会随着时间的推移而恶化。患者会出现震颤、僵硬和动作缓慢等运动症状,以及睡眠问题、便秘、焦虑、抑郁和疲劳等非运动症状。多巴胺能药物是治疗帕金森病运动症状的关键药物。左旋多巴(左旋多巴)是控制运动症状的“黄金标准”药物。由于疾病的进展,口服左旋多巴的有效性随着时间的推移而降低,出现“延迟开”、“不开”和不可预测的“开-关”期等运动波动。这些运动波动很大程度上影响了患者的生活质量,患者在完成日常生活方面存在问题。胃肠(GI)问题作为常见的非运动症状,是PD进展过程中由于口服治疗不充分而引起运动波动的最重要原因。当口服治疗不够时,需要不受胃肠道问题影响的非口服治疗。本文综述了PD早期和晚期的治疗策略、开发和批准的非口服给药系统。
{"title":"Non-Oral Drug Delivery in Parkinson's Disease: Current Applications and Future.","authors":"Meliha Güneş,&nbsp;Sinem Yaprak Karavana","doi":"10.4274/tjps.galenos.2021.95226","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.95226","url":null,"abstract":"<p><p>Parkinson's disease (PD) is a type of movement disorder that affects the ability to perform daily activities. It is considered that 1 million people in the U.S. and more than 10 million people worldwide live with PD. It is a chronic and progressive disease, so symptoms worsen over the time. Patients experience motor symptoms such as tremors, stiffness and slow motion, and non-motor symptoms such as sleep problems, constipation, anxiety, depression and fatigue. Dopaminergic drugs are critical for treating motor symptoms in PD. Levodopa (L-DOPA) is the \"gold standard\" medication for the control of motor symptoms. Because of the progression of the disease, the effectiveness of oral L-DOPA decreases over time and motor fluctuations such as \"delayed ON\", \"no ON\" and unpredictable \"ON-OFF\" periods appear. These motor fluctuations affect the quality of life of the patient at a high rate and the patient has problems in fulfilling his daily morning routines. Gastrointestinal (GI) problems, as the common non-motor symptom, are the most important cause of motor fluctuations that occur because of inadequate oral treatment with the progression of PD. When oral treatments are not sufficient, non-oral treatments that are not affected by GI problems are required. In this review, the treatment strategies, developed and approved non-oral drug delivery systems in the early and advanced stages of PD are emphasized.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 3","pages":"343-352"},"PeriodicalIF":1.7,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254083/pdf/TJPS-19-343.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40462260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
A Folk Medicine: Passiflora incarnata L. Phytochemical Profile with Antioxidant Potency. 民间药物:西番莲的抗氧化活性。
IF 1.7 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-06-27 DOI: 10.4274/tjps.galenos.2021.88886
Helan Soundra Rani Michael, Nazneen Bobby Mohammed, Subramaniam Ponnusamy, Wesely Edward Gnanaraj

Objectives: Passiflora incarnata L., commonly called folk medicine declaredly used for an enormous range of therapeutic purposes, one such is antioxidant potency. The study prioritized to determine the phytochemical analysis of total phenolics, flavonoids, alkaloids, and tannins contents as well as the antioxidant properties through 1,1-diphenyl-2-picrylhydrazyl (DPPH) quenching assay, 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) cation decolorization test, superoxide, and hydrogen peroxide radical scavenging assays of ethanol extract of P. incarnata leaves.

Materials and methods: The organoleptic characteristics such as color, odor, appearance, taste, and other characters such as drying range and fiber contents were analyzed as preliminary data. Analytical parameters like total phenolic content, total tannins, total alkaloid content, and total flavonoid with multiple antiradical scavenging activity (DPPH, ABTS, superoxide and H2O2 scavenging assays) with IC50 (μg/mL) in terms of inhibition percentage with various concentrations of the ethanolic extract studied.

Results: P. incarnata possessed a high radical scavenging activity with a phenolic content of 2.48 mg gallic acid equivalent/g of extract in leaves, whereas the total flavonoid content was 2.1, respectively.

Conclusion: High antioxidant activity was noticed in P. incarnata extract, in which might be of higher levels of flavonoids and phenols. Findings in the studies revealed that P. incarnata is a veritable source for antioxidant drug bioprospecting in scientific research and pharmaceutical industries.

目的:西番莲(Passiflora incarnata L.),通常被称为民间药物,用于广泛的治疗目的,其中之一是抗氧化效力。通过1,1-二苯基-2-苦味酰肼(DPPH)猝灭试验、2,2-氮基-双-(3-乙基苯并噻唑啉-6-磺酸)阳离子脱色试验、超氧化物和过氧化氢自由基清除试验,对红花叶乙醇提取物的总酚类、类黄酮、生物碱和单宁含量进行了植物化学分析,并对其抗氧化性能进行了研究。材料与方法:对其色、香、形、味等感官特征及干燥范围、纤维含量等其他性状进行初步分析。总酚含量、总单宁含量、总生物碱含量、总黄酮等分析参数对不同浓度乙醇提取物的抑制率均达到IC50 (μg/mL),具有多种抗自由基清除活性(DPPH、ABTS、超氧化物和H2O2清除试验)。结果:红枣叶中酚类物质含量为2.48 mg没食子酸当量/g,总黄酮含量为2.1 mg /g,具有较强的自由基清除能力。结论:红皮提取物具有较高的抗氧化活性,可能与红皮提取物中黄酮类和酚类物质含量较高有关。研究结果表明,在科学研究和制药工业中,螺旋藻是一种名副其实的抗氧化药物生物勘探来源。
{"title":"A Folk Medicine: <i>Passiflora incarnata</i> L. Phytochemical Profile with Antioxidant Potency.","authors":"Helan Soundra Rani Michael,&nbsp;Nazneen Bobby Mohammed,&nbsp;Subramaniam Ponnusamy,&nbsp;Wesely Edward Gnanaraj","doi":"10.4274/tjps.galenos.2021.88886","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.88886","url":null,"abstract":"<p><strong>Objectives: </strong><i>Passiflora incarnata</i> L., commonly called folk medicine declaredly used for an enormous range of therapeutic purposes, one such is antioxidant potency. The study prioritized to determine the phytochemical analysis of total phenolics, flavonoids, alkaloids, and tannins contents as well as the antioxidant properties through 1,1-diphenyl-2-picrylhydrazyl (DPPH) quenching assay, 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) cation decolorization test, superoxide, and hydrogen peroxide radical scavenging assays of ethanol extract of <i>P. incarnata</i> leaves.</p><p><strong>Materials and methods: </strong>The organoleptic characteristics such as color, odor, appearance, taste, and other characters such as drying range and fiber contents were analyzed as preliminary data. Analytical parameters like total phenolic content, total tannins, total alkaloid content, and total flavonoid with multiple antiradical scavenging activity (DPPH, ABTS, superoxide and H<sub>2</sub>O<sub>2</sub> scavenging assays) with IC<sub>50</sub> (μg/mL) in terms of inhibition percentage with various concentrations of the ethanolic extract studied.</p><p><strong>Results: </strong><i>P. incarnata</i> possessed a high radical scavenging activity with a phenolic content of 2.48 mg gallic acid equivalent/g of extract in leaves, whereas the total flavonoid content was 2.1, respectively.</p><p><strong>Conclusion: </strong>High antioxidant activity was noticed in <i>P. incarnata</i> extract, in which might be of higher levels of flavonoids and phenols. Findings in the studies revealed that <i>P. incarnata</i> is a veritable source for antioxidant drug bioprospecting in scientific research and pharmaceutical industries.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 3","pages":"287-292"},"PeriodicalIF":1.7,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254093/pdf/TJPS-19-287.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40468737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Turkish Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1